Immix Biopharma, Inc. — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Immix Biopharma filed Form 8-K on July 20, 2026, reporting Item 8.01 (Other Events). The filing does not provide specific substantive disclosures in the text supplied—only structural metadata and XBRL filing documentation. No counterparties, dollar amounts, share counts, dates of material events, or concrete operational changes are detailed in the excerpt provided.
Why this rating
No material event disclosed in excerpt. Filing is routine administrative disclosure with no specifics on business impact.
Extracted items
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.